This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).

Dissertation (Ph.D.) -- University of Texas Southwestern Medical Center at Dallas, 2007. / Vita. Bibliography: p. 104-105

<p>Persons suffering from Attention deficit/hyperactivity disorder (ADHD) struggle with complications within the functions that regulate and control the brain activities, due to deficiencies in these functions within the affected nerve-paths. ADHD is a cognitive function impairment characterised by inattention, impulsiveness and over activity. According to Diagnostic and Statistic Manual of Mental Disorders, American Psychiatric Association (DSM-IV), certain diagnostic criteria of ADHD must be fulfilled in order for a person to be diagnosed with ADHD. The everyday problems caused by ADHD are individual and medication can have positive effects relieving the person’s impairing behaviour. The study is based on scientific literature, three quantitative scientific articles and preview material from the last study by Johnson, Fransson, Kadesjö & Gillberg, presently being scrutinised. Swedish as well as English literature has been used. The purpose of this study is to shed some light upon whether medication facilitates the child’s school situation. The result deals with the ADHD diagnosis and pharmacological therapy involving drugs that stimulate the central nervous system, as well as naturopathic medicine like Omega-3/6. The pedagogical aspect for children with ADHD in school has been observed and evaluated. In this matter it is important for the pedagogue to encourage the child by letting it find out that it can manage more than it thinks.</p>

Persons suffering from Attention deficit/hyperactivity disorder (ADHD) struggle with complications within the functions that regulate and control the brain activities, due to deficiencies in these functions within the affected nerve-paths. ADHD is a cognitive function impairment characterised by inattention, impulsiveness and over activity. According to Diagnostic and Statistic Manual of Mental Disorders, American Psychiatric Association (DSM-IV), certain diagnostic criteria of ADHD must be fulfilled in order for a person to be diagnosed with ADHD. The everyday problems caused by ADHD are individual and medication can have positive effects relieving the person’s impairing behaviour. The study is based on scientific literature, three quantitative scientific articles and preview material from the last study by Johnson, Fransson, Kadesjö &amp; Gillberg, presently being scrutinised. Swedish as well as English literature has been used. The purpose of this study is to shed some light upon whether medication facilitates the child’s school situation. The result deals with the ADHD diagnosis and pharmacological therapy involving drugs that stimulate the central nervous system, as well as naturopathic medicine like Omega-3/6. The pedagogical aspect for children with ADHD in school has been observed and evaluated. In this matter it is important for the pedagogue to encourage the child by letting it find out that it can manage more than it thinks.

Syfte: Att undersöka om det fanns något samband mellan behandling med centralstimulantia ochavvikande tillväxt hos barn och ungdomar med ADHD, samt att undersöka om eventuellt avvikandetillväxt hade något samband med ålder vid insättande, kön eller olika funktionshinder.Metod: 68 barn med ADHD som behandlats med centralstimulantia i minst två år inkluderades.Journalkopior inhämtades från Habiliteringen för barn och vuxna vid Uppsala läns landsting. Dessakopior innehöll barnens tillväxtkurvor, kön, diagnos och ålder. Kurvorna granskades med hjälp av enutformad granskningsmall. Barnens tillväxt jämfördes mellan åldergrupper, kön och olikafunktionshinder.Resultat: Vid behandlingsstart var åldersgrupperna 6-8 år samt 12-16 år signifikant tyngre ännormalpopulationen i samma åldersgrupper. Det fanns en signifikant skillnad mellan åldergrupperna ilängdavplaning efter ett års behandling, där fler barn i åldrarna 10-16 år avplanade än barn i åldrarna6-10 år. Även mellan funktionshindergrupperna fanns det en signifikant skillnad i längdavplaning eftertvå års behandling. Mellan pojkar och flickor fanns det en signifikant skillnad i viktavplaning efter tvåårs behandling, där fler pojkar avvek nedåt från sin tillväxtkurva.Slutsats: Det framkom få samband mellan behandling med centralstimulantia och avvikande tillväxthos barn och ungdomar med ADHD. Ett litet urval i denna journalgranskning innebar låg power i destatistiska analyserna vilket medförde svårigheter att påvisa signifikanta samband och skillnadermellan de grupper som jämförts. Avplaning i tillväxt vid centralstimulantiabehandling är ett viktigtansvarsområde för sjuksköterskan som bör observera och arbeta förebyggande för att undvika detta.Författarna vidhåller att detta är ett viktigt ämne som berör många barn, föräldrar och sociala instanser,vilket gör det önskvärt med fler större studier som undersöker detta mer grundligt. / Objective: To study whether there was any relation between treatment with stimulants and abnormalgrowth in children and adolescents with ADHD, and to study whether any differences in growth wasrelated to age at initiation, gender or different disabilities.Design: 68 children with ADHD treated with stimulants for at least two years were included. Journalcopies were collected from Habiliteringen vid Uppsala län. These copies contained the children'sgrowth charts, gender, diagnosis and age. These curves were studied using a designed review template.Children's growth was compared between age groups, gender and disabilities.Results: At baseline, the age groups 6-8 years and 12-16 years were significantly heavier than normalpopulation of same age groups. There was a significant difference between age groups in decrease inlength after one year of treatment where more children aged 10-16 years decreases than children aged6-10 years. Also among other disability groups, there was a significant difference in decrease in lengthafter two years of treatment. Between boys and girls, there was a significant difference in decrease inweight after two years of treatment, where more boys departed downward from its growth curve.Conclusion: There were few correlations between treatment with stimulants and abnormal growth inchildren and adolescents with ADHD. A small sample in this journal review meant low power in thestatistical analysis leading to an inability to detect significant correlation and differences between thegroups for comparison. Decrese in growth during treatment with stimulants is an importantresponsibility for the nurse who should observe and work preventively to avoid this. The authorsmaintain that this is an important topic that affects many children, parents and social instances, makingit desirable for more major studies to investigate this more thoroughly.

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 6 uppsatser.

Thesis (Ph.D.)--University of Alberta, 2010. / A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Centre of Neuroscience. Title from pdf file main screen (viewed on April 18, 2010). Includes bibliographical references.

Thesis (Ph. D.)--University of Wisconsin, 1954. / Typescript (carbon copy). eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves [53]-[60]).

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 4 uppsatser.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 4 uppsatser.